Representing @TheYadenLab at @JHPsychedelics & @psychedelethics at @FDA. Postdoc Eddie Jacobs @eddietalksdrugs spoke to how the evidence on psychedelic treatments comes from clinical trials, so those safeguards should be used for initial roll-out, to be adjusted based on data…
We want to hear your opinions about clinical trial research! What are the reasons you might not be able to join a clinical trial?
We are conducting a survey study to understand concerns and challenges related to clinical trial participation, including factors influencing willingness to join psychedelic trials. Tell us your thoughts at https://t.co/Zr4wCYE2FI
Enjoyed speaking about psychedelic science for @profsandpints at @guilfordbrewery!
Our lab aims to get out to do more public science communication on psychedelics facts and research findings. Thanks for all the great questions 🍻
Thrilled to have worked on this with amazing co-authors @briandavidearp@ExistWell@KRPatch - paper thread soon! Tldr: psychedelics may appear unusual or unique, & their ethical issues exceptional. But might they be more similar to other interventions than first meets the eye?
Patrick Finan and I recently had the chance to discuss the safety and potential efficacy of psilocybin for treating chronic lower back pain and depression and our ongoing clinical trial seeking to answer that question on the @accracpodcast - check it out!
Very happy to finally have THE major chunk of my PhD out! @TIFRScience
Grateful to all the coauthors for their amazing contribution to this work.
Key highlights of the paper from @ViditaVaidya quoted below. But there are some side nuggets also - summarizing in a thread here:
We are hiring a new research coordinator to work with Dr. Ceyda Sayali (@CeydaSayali), using neurostimulation methods such as Transcranial Magnetic Stimulation to study the effects of psychedelics. Learn more and apply at https://t.co/TExGMROL0f
It was a delight presenting at @cogscicbcs
I had been meaning to visit the center for a while and finally got the chance to do so. Thank you for having me :)
This is a very nice pre-print. Inching closer to actual evidence for anatomical neuroplasticity in living human brain. Many seem unaware we don't yet have such evidence https://t.co/UFc0OFkshW
🔬Our new paper in @NatRevPsych outlines the limitations of our understanding of psychedelics' subjective effects & how we can improve our science moving forward, going beyond just mystical experience.
Proud to be a part of this with @ExistWell, @BWe1ss, & Roland Griffiths.
It’s high time the field of psychedelic research move beyond the mystical experience construct (MEQ).
While many critiques of the measure rest on misconceptions, persistent misunderstandings & psychometric limitations lead us to recommend transcending it.
The CPCR was a co-sponsor of the HOPE Summit 2024 this past weekend - an event focused on discussing psychedelic ethics and aims to identify ways to improve the field as a whole.
Photo credits to @DrKeishaRay 😊
@psychedelethics@bermaninstitute@ethicsinthenews
Researchers at Johns Hopkins University are seeking individuals with chronic low back pain and co-occurring depression to participate in a research study on the effects of psilocybin and whether or not it can help with chronic low back pain and co-occurring depression.
Email us at [email protected] or visit the link below to apply! https://t.co/SVn1T0r5Zi
Principal Investigator: David B. Yaden, Ph.D.
Protocol: IRB00385932
New @NIH_NCCIH study launching: Psilocybin and Affective Function in Chronic Low Back Pain and Depression (CLBP+D). Me & @p_fi are Co-PIs.
CLPB+D is among the leading causes of disability in the US.
Now recruiting! Please spread the word and/or send ideas for study recruitment.